Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 861

1.

Prostate cancer dose-response, fractionation sensitivity and repopulation parameters evaluation from 25 international radiotherapy outcome data sets.

Tamponi M, Gabriele D, Maggio A, Stasi M, Meloni GB, Conti M, Gabriele P.

Br J Radiol. 2019 Apr 24:20180823. doi: 10.1259/bjr.20180823. [Epub ahead of print]

PMID:
31017457
2.

Atypical Carcinoid of the Larynx.

Crosetti E, Arrigoni G, Cerutti M, Succo G.

Ear Nose Throat J. 2019 Apr 23:145561319840157. doi: 10.1177/0145561319840157. [Epub ahead of print] No abstract available.

PMID:
31012344
3.

Swallowing Safety and Efficiency after Open Partial Horizontal Laryngectomy: A Videofluoroscopic Study.

Pizzorni N, Schindler A, Castellari M, Fantini M, Crosetti E, Succo G.

Cancers (Basel). 2019 Apr 17;11(4). pii: E549. doi: 10.3390/cancers11040549.

4.

Stress responses in stromal cells and tumor homeostasis.

Vitale I, Manic G, Galassi C, Galluzzi L.

Pharmacol Ther. 2019 Apr 15. pii: S0163-7258(19)30061-0. doi: 10.1016/j.pharmthera.2019.04.004. [Epub ahead of print]

PMID:
30998941
5.

Self-Organized Nuclear Positioning Synchronizes the Cell Cycle in Drosophila Embryos.

Deneke VE, Puliafito A, Krueger D, Narla AV, De Simone A, Primo L, Vergassola M, De Renzis S, Di Talia S.

Cell. 2019 Apr 9. pii: S0092-8674(19)30269-7. doi: 10.1016/j.cell.2019.03.007. [Epub ahead of print]

PMID:
30982601
6.

A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.

Corti G, Bartolini A, Crisafulli G, Novara L, Rospo G, Montone M, Negrino C, Mussolin B, Buscarino M, Isella C, Barault L, Siravegna G, Siena S, Marsoni S, Di Nicolantonio F, Medico E, Bardelli A.

Clin Colorectal Cancer. 2019 Mar 7. pii: S1533-0028(18)30588-7. doi: 10.1016/j.clcc.2019.02.008. [Epub ahead of print]

PMID:
30981604
7.

INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases.

Beekhof R, van Alphen C, Henneman AA, Knol JC, Pham TV, Rolfs F, Labots M, Henneberry E, Le Large TY, de Haas RR, Piersma SR, Vurchio V, Bertotti A, Trusolino L, Verheul HM, Jimenez CR.

Mol Syst Biol. 2019 Apr 12;15(4):e8250. doi: 10.15252/msb.20188250.

8.

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.

Pignata S, Scambia G, Lorusso D, De Giorgi U, Nicoletto MO, Lauria R, Mosconi AM, Sacco C, Omarini C, Tagliaferri P, Ferrandina G, Cinieri S, Savarese A, Valabrega G, Pisano C, Salutari V, Raspagliesi F, Kopf B, Cecere SC, Amadio G, Maltese G, Di Napoli M, Greggi S, Signoriello S, Daniele G, Sacco A, Losito S, Normanno N, Perrone F, Gallo C, Piccirillo MC; MITO Investigators.

Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30495-0. doi: 10.1016/j.ygyno.2019.03.260. [Epub ahead of print]

PMID:
30979589
9.

Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine.

Varamo C, Peraldo-Neia C, Ostano P, Basiricò M, Raggi C, Bernabei P, Venesio T, Berrino E, Aglietta M, Leone F, Cavalloni G.

Cancers (Basel). 2019 Apr 11;11(4). pii: E519. doi: 10.3390/cancers11040519.

10.

Peering through a keyhole: Liquid biopsy in primary and metastatic central nervous system tumours.

Bertero L, Siravegna G, Rudà R, Soffietti R, Bardelli A, Cassoni P.

Neuropathol Appl Neurobiol. 2019 Apr 12. doi: 10.1111/nan.12553. [Epub ahead of print] Review.

PMID:
30977933
11.

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.

Nature. 2019 Apr 10. doi: 10.1038/s41586-019-1103-9. [Epub ahead of print]

PMID:
30971826
12.

HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.

Sartore-Bianchi A, Amatu A, Porcu L, Ghezzi S, Lonardi S, Leone F, Bergamo F, Fenocchio E, Martinelli E, Borelli B, Tosi F, Racca P, Valtorta E, Bonoldi E, Martino C, Vaghi C, Marrapese G, Ciardiello F, Zagonel V, Bardelli A, Trusolino L, Torri V, Marsoni S, Siena S.

Oncologist. 2019 Apr 5. pii: theoncologist.2018-0785. doi: 10.1634/theoncologist.2018-0785. [Epub ahead of print]

PMID:
30952821
13.

Dematerialisation of patient's informed consent in radiology: insights on current status and radiologists' opinion from an Italian online survey.

Coppola F, Faggioni L, Grassi R, Bibbolino C, Rizzo A, Gandolfo N, Calvisi A, Cametti CA, Benea G, Giovagnoni A, Privitera C, Regge D.

Radiol Med. 2019 Apr 2. doi: 10.1007/s11547-019-01033-9. [Epub ahead of print]

PMID:
30941634
14.

Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients.

Peraldo-Neia C, Scatolini M, Grosso E, Lombardi P, Filippi R, Raggi C, Marchiò C, Cavalloni G, Aglietta M, Leone F.

Cancers (Basel). 2019 Mar 30;11(4). pii: E454. doi: 10.3390/cancers11040454.

15.

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity.

Martinello R, Becco P, Vici P, Airoldi M, Del Mastro L, Garrone O, Barone C, Pizzuti L, D'Alonzo A, Bellini E, Milani A, Bonzano A, Montemurro F.

Breast J. 2019 Apr 1. doi: 10.1111/tbj.13240. [Epub ahead of print]

PMID:
30932296
16.

Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study.

Van De Sande L, Graversen M, Hubner M, Pocard M, Reymond M, Vaira M, Cosyns S, Willaert W, Ceelen W.

Pleura Peritoneum. 2018 Jun 8;3(2):20180112. doi: 10.1515/pp-2018-0112. eCollection 2018 Jun 1.

17.

Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number variation in 3p26.2 and 8q24.3.

Ballabio S, Craparotta I, Paracchini L, Mannarino L, Corso S, Pezzotta MG, Vescio M, Fruscio R, Romualdi C, Dainese E, Ceppi L, Calura E, Pileggi S, Siravegna G, Pattini L, Martini P, Delle Marchette M, Mangioni C, Ardizzoia A, Pellegrino A, Landoni F, D'Incalci M, Beltrame L, Marchini S.

Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32288. [Epub ahead of print]

PMID:
30892690
18.

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.

Urbini M, Indio V, Tarantino G, Ravegnini G, Angelini S, Nannini M, Saponara M, Santini D, Ceccarelli C, Fiorentino M, Vincenzi B, Fumagalli E, Casali PG, Grignani G, Pession A, Ardizzoni A, Astolfi A, Pantaleo MA.

Genes Chromosomes Cancer. 2019 Mar 19. doi: 10.1002/gcc.22753. [Epub ahead of print]

PMID:
30887595
19.

Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience.

Fenocchio E, Colombi F, Calella MG, Filippi R, Depetris I, Chilà G, Lombardi P, Marino D, Cagnazzo C, Ferraris R, Vaira M, Aglietta M, Leone F.

Cancers (Basel). 2019 Mar 15;11(3). pii: E369. doi: 10.3390/cancers11030369.

20.

Arytenoid Fixation in Laryngeal Cancer: Radiological Pictures and Clinical Correlations with Respect to Conservative Treatments.

Succo G, Cirillo S, Bertotto I, Maldi E, Balmativola D, Petracchini M, Gned D, Fornari A, Motatto GM, Sprio AE, Manca A, Crosetti E.

Cancers (Basel). 2019 Mar 13;11(3). pii: E360. doi: 10.3390/cancers11030360.

Supplemental Content

Loading ...
Support Center